R. Sheng, B. Badillo, J. Jiang, X. Gao, T. Ramalingam, M. Bengus, M. Neighbors
{"title":"基线生物标志物水平与早期ILD、不可分类ILD、IPF、晚期IPF和系统性硬化症临床试验队列中的纤维化程度相关","authors":"R. Sheng, B. Badillo, J. Jiang, X. Gao, T. Ramalingam, M. Bengus, M. Neighbors","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4234","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":232779,"journal":{"name":"TP107. TP107 PULMONARY FIBROSIS: MOLECULAR AND CELLULAR MECHANISMS","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Baseline Biomarker Levels Correlate with Degree of Fibrosis in Early ILD, Unclassifiable ILD, IPF, Advanced IPF, and Systemic Sclerosis Clinical Trial Cohorts\",\"authors\":\"R. Sheng, B. Badillo, J. Jiang, X. Gao, T. Ramalingam, M. Bengus, M. Neighbors\",\"doi\":\"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4234\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":232779,\"journal\":{\"name\":\"TP107. TP107 PULMONARY FIBROSIS: MOLECULAR AND CELLULAR MECHANISMS\",\"volume\":\"4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"TP107. TP107 PULMONARY FIBROSIS: MOLECULAR AND CELLULAR MECHANISMS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4234\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP107. TP107 PULMONARY FIBROSIS: MOLECULAR AND CELLULAR MECHANISMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Baseline Biomarker Levels Correlate with Degree of Fibrosis in Early ILD, Unclassifiable ILD, IPF, Advanced IPF, and Systemic Sclerosis Clinical Trial Cohorts